# Umifenovir in Hospitalized COVID-19 Patients

> **NCT04350684** · PHASE4 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Umifenovir
- **DRUG:** Interferon-β 1a
- **DRUG:** Lopinavir / Ritonavir
- **DRUG:** Single Dose of Hydroxychloroquine
- **DRUG:** Standards of Care

## Key facts

- **NCT ID:** NCT04350684
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-15
- **Primary completion:** 2020-04-22
- **Final completion:** 2020-04-24
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04350684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04350684, "Umifenovir in Hospitalized COVID-19 Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04350684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*